Non-steroidal anti-inflammatory drugs and variceal bleeding: A case-control study

被引:17
作者
deLedinghen, V
Mannant, PR
Foucher, J
Perault, MC
Barrioz, T
Ingrand, P
Vandel, B
Silvain, C
Beauchant, M
机构
[1] CHU POITERS,SERV HEPATOL,POITIERS,FRANCE
[2] CHU POITERS,SERV PHARMACOL CLIN,POITIERS,FRANCE
[3] CHU POITERS,UNITE BIOSTAT,POITIERS,FRANCE
关键词
esophageal variceal bleeding; nonsteroidal anti-inflammatory drugs; portal hypertension;
D O I
10.1016/S0168-8278(96)80142-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aim: The aim of this case-control study was to assess the risk of bleeding from esophageal varices associated with aspirin and non-steroidal anti-inflammatory drug consumption. Methods: Between January 1992 and May 1994, patients admitted for bleeding from esophageal or gastric lesions related to portal hypertension were matched with a control patient of the same age and sex, who was free of gastrointestinal bleeding, A structured interview was conducted with the cases and controls to determine drug consumption during the 2 weeks preceding admission, Fifty-nine cases and 59 controls were recruited. Results/Conclusions: Use of aspirin was more prevalent among the cases than the controls (odds ratio 3.81; 95% confidence interval 1.36-11.64; p=0.004). This difference remained significant in the subgroups of patients with a first episode of variceal bleeding (odds ratio 3.9; 95% confidence interval 1.2-13.9, p=0.01), but was not significant in the subgroups of patients with a recurrent episode of variceal bleeding, The use of aspirin was associated with a high risk of a first episode of variceal bleeding, suggesting that patients with portal hypertension should avoid taking these drugs.
引用
收藏
页码:570 / 573
页数:4
相关论文
共 50 条
  • [41] Non-steroidal anti-inflammatory drugs and the continuum of renal dysfunction
    Epstein, M
    JOURNAL OF HYPERTENSION, 2002, 20 : S17 - S23
  • [42] Comparative incidence of upper gastrointestinal bleeding associated with individual non-steroidal anti-inflammatory drugs
    Melero, MJL
    Burillo, JMT
    Marcet, AZ
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2002, 94 (01) : 13 - 18
  • [43] Delayed contact hypersensitivity to non-steroidal anti-inflammatory drugs
    Gniazdowska, B
    Ruëff, F
    Przybilla, B
    CONTACT DERMATITIS, 1999, 40 (02) : 63 - 65
  • [44] Choosing and using non-steroidal anti-inflammatory drugs in haemophilia
    Arachchillage, D. R. J.
    Makris, M.
    HAEMOPHILIA, 2016, 22 (02) : 179 - 187
  • [45] Non-Steroidal Anti-Inflammatory Drugs in the Carcinogenesis of the Gastrointestinal Tract
    Compare, Debora
    Nardone, Olga
    Nardone, Gerardo
    PHARMACEUTICALS, 2010, 3 (08): : 2495 - 2516
  • [46] Relationship between non-steroidal anti-inflammatory drug use and Helicobacter pylori infection in bleeding or uncomplicated peptic ulcers:: A case-control study
    Okan, A
    Tankurt, E
    Aslan, BU
    Akpinar, H
    Simsek, I
    Gonen, O
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 18 (01) : 18 - 25
  • [47] Interaction between Helicobacter pylori and non-steroidal anti-inflammatory drugs in peptic ulcer bleeding
    Wu, CY
    Poon, SK
    Chen, GH
    Chang, CS
    Yeh, HZ
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1999, 34 (03) : 234 - 237
  • [48] Physicochemical Interaction Study of Non-Steroidal Anti-Inflammatory Drugs with Dimyristoylphosphatidylethanolamine Liposomes
    Manrique-Moreno, Marcela
    Howe, Joerg
    Suwalsky, Mario
    Garidel, Patrick
    Brandenburg, Klaus
    LETTERS IN DRUG DESIGN & DISCOVERY, 2010, 7 (01) : 50 - 56
  • [49] Potency of non-steroidal anti-inflammatory drugs in chemotherapy (Review)
    Hil'ovska, Lucia
    Jendzelovsky, Rastislav
    Fedorocko, Peter
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (01) : 3 - 12
  • [50] The Invisible Threat of Non-steroidal Anti-inflammatory Drugs for Kidneys
    Clave, Stephanie
    Rousset-Rouviere, Caroline
    Daniel, Laurent
    Tsimaratos, Michel
    FRONTIERS IN PEDIATRICS, 2019, 7